Skip to content

The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III

The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05408351
Enrollment
131
Registered
2022-06-07
Start date
2019-11-01
Completion date
2019-12-31
Last updated
2022-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Development, Child Development Disorder, Developmental Delay, Development Delay, Global Developmental Delay, Motor Delay, Speech Delay

Keywords

ASQ-3, BSID-III, child development, Indonesia, screening test, validity

Brief summary

This study aimed to evaluate the concurrent validity information of the 24-, 30-, and 36-month Indonesian ASQ-3 with the Bayley Scales of Infant and Toddler Development 3rd Edition (BSID-III) in Indonesian children. Children living in Tanah Tinggi subdistrict, Central Jakarta, were recruited conveniently from November to December 2019. Children within the 24-, 30-, or 36-month age group were assessed for Indonesian ASQ-3 concurrently with BSID-III as the reference standard according to their age groups. Screening test accuracy was measured in sensitivity, specificity, and predictive values for both overall dan specific domains.

Interventions

None listed

Sponsors

Indonesia University
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
23 Months to 38 Months
Healthy volunteers
Yes

Inclusion criteria

* Parents with children aged 23 - 38 months * Parents who finished at least elementary school

Exclusion criteria

* Parents with communication difficulties * Parents who could not speak Indonesian language

Design outcomes

Primary

MeasureTime frameDescription
Child developmentDay 1Measured once with Indonesian Ages and Stages-3 questionnaire (cross sectional study) with scores ranging between 0 to 60 per domain. Higher score means better development.

Countries

Indonesia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026